Aortic valve replacement with stentless bioprosthesis «Kemerovo-AB-NEO»

Автор: Astapov D.A., Karaskov A.M., Isayan M.V., Semenova E.I., Demidov D.P., Open A.B.

Журнал: Патология кровообращения и кардиохирургия @journal-meshalkin

Рубрика: Приобретенные пороки сердца

Статья в выпуске: 1 т.16, 2012 года.

Бесплатный доступ

We analyzed 50 aortic valve replacements (AVR) with «Kemerovo-AB-Neo» stentless bioprostheses. Mean age was 66.7±5 (54 to78) years, hospital mortality rate accounted for 2%. The peak transprosthetic pressure gradient (PTPG) in patients operated for aortic stenosis came to 19.5±7 mm Hg. PTPG was shown to be dependent on the implantation technique; it reached 24.5±7 mm Hg when in order to fix the proximal line, interrupted sutures were used and ran to 17±5 mm Hg in the case of running sutures (р = 0.03). Helical CT confirmed fine mobility of the cardiac structures after «Kemerovo-AB-Neo» implantation: the aortic cross-section area varied up to 84% during the cardiac cycle. It should be noted that AVR with «Kemerovo-AB-Neo» stentless valves gives good clinical and hemodynamic results early after surgery. A «free-hand» technique of implantation should be preferred. The implantation of stentless bioprostheses retains cardiac structures mobility and natural aortic root dimensions after performing an AVR.

Еще

Aortic defect, heart valve bioprosthesis

Короткий адрес: https://sciup.org/142140451

IDR: 142140451

Статья научная